Patent · US Active

Sepiapterin reductase inhibitors

US9963462B2 · kind B2 · utility

0Cited by
20References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 30, 2016
Grant dateMay 8, 2018
Priority date—
Expiry dateSep 30, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Inhibitors of sepiapterin reductase and uses of sepiapterin reductase inhibitors in analgesia, treatment of acute and chronic pain, anti-inflammation, and immune cell regulation are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.